Canadians warn patients against Avandia

More limits on Avandia use, this time from Canadian regulators. While the FDA continues to debate adding various warnings to GlaxoSmithKline's embattled diabetes drug, HealthCanada has induced GSK to release new, restrictive guidelines.

According to GSK's Dear Doctor letter, the drug should never be used in a patient with heart failure, not even in the early stages. The drug can be added to metformin treatment, but only if metformin alone doesn't work. And Avandia should only be used on its own or with sulfa drugs if the patient can't tolerate metformin or has tried metformin without success. And it shouldn't be taken with insulin.

- see the "Dear Health Care Professional" letter at HealthCanada
- check out this item at Pharmalot
- read the report from The Record

Related Articles:
Avandia cleared FDA by one vote. Report
GSK plant closure begins 5,000 job cuts. Report
Teva inks deal to sell generic Avandia. Report
Avandia, Actos don't boost death risk. Report
FDA adds to drumbeat of bad news for Avandia. Report
Expert committee says Avandia should stay. Report

Suggested Articles

While Lilly's 2018 launch Emgality is approved to prevent migraines, Reyvow is intended to treat them as they occur.

ICER's new draft review of RA drugs takes a different approach, reflecting how physicians treat the disease and the time horizon that's considered.

Johnson & Johnson is facing multibillion-dollar liabilities in thousands of talc and opioid cases. But that's not such a bad thing, one analyst said.